Belite Bio

BLTE · NASDAQ

$154.45+$7.11 (+4.83%)TodayMarket closed ·
Prev close $147.34

Who owns BLTE

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 60.8% of BLTE’s shares.

  • Lin Bioscience International, Ltd.42.6%
  • Darwin Global Management Ltd7.7%
  • Paradigm BioCapital Advisors LP3.1%
  • RTW Investments L.P.1.8%
  • Next 6 largest institutions5.7%
  • All other shareholders39.2%
Top institutional holders of BLTE
HolderShares% of shares
Lin Bioscience International, Ltd.17.10M42.64%
Darwin Global Management Ltd3.08M7.68%
Paradigm BioCapital Advisors LP1.23M3.08%
RTW Investments L.P.715.33K1.78%
Millennium Management LLC494.56K1.23%
Maverick Capital, Ltd.396.31K0.99%
Eventide Asset Management, LLC390.83K0.97%
Deerfield Management Company, L.P.357.20K0.89%
Lin (Yu-Hsin)343.52K0.86%
Chuang (Hao-Yuan)288.70K0.72%

Largest mutual fund holders

Top mutual fund holders of BLTE
HolderShares% of shares
MEDICAL BioHealth112.48K0.28%
Candriam Equities L Biotechnology62.84K0.16%
UPAMC Global AIoT Fund48.01K0.12%
Eventide Healthcare & Life Sciences Fund29.03K0.07%
APO Medical Opportunities21.90K0.05%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $35.74M (140 trades) of BLTE on the open market, with no buys.

Latest BLTE insider transactions
InsiderTypeSharesValue
Scholl Hendrik PeterSale2$340
Scholl Hendrik PeterSale14$2.37K
Scholl Hendrik PeterSale12$2.02K
Scholl Hendrik PeterSale78$13.07K
Scholl Hendrik PeterSale50$8.32K
Scholl Hendrik PeterSale120$19.86K
Scholl Hendrik PeterSale24$3.95K
Scholl Hendrik PeterSale200$32.73K
Lin Yu-HsinSale2.70K$534.84K
Lin Yu-HsinSale8.75K$1.73M

Short interest

Settled Sep 30, 2026

Shares short
1.06M
Days to cover
7.28
% of shares outstanding
2.64%
Average daily volume
145.21K
Change since last report
+0.7%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.